Several analysts have recently updated their ratings and price targets for Seattle Genetics (NASDAQ: SGEN): 12/17/2019 – Seattle Genetics was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 12/13/2019 – Seattle Genetics had its “buy” rating reaffirmed by analysts at William Blair. 12/13/2019 – Seattle Genetics had its “buy” rating […]